Comparison between Bizotic Commercial IPO and Cell Point IPO.
IPO Details
Bizotic Commercial IPO is a SME Fixed Price IPO proposed to list at BSE SME while Cell Point IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Bizotic Commercial IPO is up to ₹40.10 Cr whereas the issue size of the Cell Point IPO is up to ₹47.82 Cr. The final issue price of Bizotic Commercial IPO is ₹175.00 per share and of Cell Point IPO is ₹100.00 per share.
IPO Timetable
Bizotic Commercial IPO opens on Jun 12, 2023, while Cell Point IPO opens on Jun 15, 2023. The closing date of Bizotic Commercial IPO and Cell Point IPO is Jun 15, 2023, and Jun 20, 2023, respectively.
| | Bizotic Commercial IPO | Cell Point IPO |
|---|
| Issue Open | Jun 12, 2023 | Jun 15, 2023 |
| Issue Close | Jun 15, 2023 | Jun 20, 2023 |
| Basis Of Allotment (Tentative) | Jun 20, 2023 | Jun 23, 2023 |
| Initiation of Refunds (Tentative) | Jun 21, 2023 | Jun 26, 2023 |
| Credit of Share (Tentative) | Jun 22, 2023 | Jun 27, 2023 |
| Listing date (Tentative) | Jun 23, 2023 | Jun 28, 2023 |
Financials & KPIs
Bizotic Commercial IPO P/E ratio is 36.38, as compared to Cell Point IPO P/E ratio of 24.1.
Shares Offered
In the Bizotic Commercial IPO Retail Individual Investors (RII) are offered 11,45,600 shares while in Cell Point IPO retail investors are offered 11,45,600 shares. Qualified Institutional Buyers (QIB) are offered in Bizotic Commercial IPO and in Cell Point IPO.
| | Bizotic Commercial IPO | Cell Point IPO |
|---|
| Market Maker Reservation | 1,20,800 shares | 2,52,000 shares |
| NII | 11,45,600 shares | 23,91,000 shares |
| RII | 11,45,600 shares | 23,91,000 shares |
| Total | 22,91,200 shares | 47,82,000 shares |
Bids Received (Subscription)
Bizotic Commercial IPO subscribed 1.87x in total, whereas Cell Point IPO subscribed 6.01x.
